XML 129 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue:      
Total revenue $ 114,617 $ 1,193,323 $ 307,711
Operating costs and expenses:      
Cost of goods sold 21,374 24,412 30,547
Research and development 434,566 399,536 268,461
General and administrative 98,712 81,443 52,364
Impairment of equipment and other costs for terminated program 0 0 15,981
Total operating costs and expenses 554,652 505,391 367,353
Income (loss) from operations (440,035) 687,932 (59,642)
Non-operating income (expense):      
Interest expense (21,310) (21,582) (22,085)
Non-cash interest expense on liability related to sale of future royalties (25,044) (21,196) (18,869)
Interest income and other income (expense), net 46,335 37,571 4,520
Total non-operating expense, net (19) (5,207) (36,434)
Income (loss) before provision for income taxes (440,054) 682,725 (96,076)
Provision for income taxes 613 1,412 616
Net income (loss) $ (440,667) $ 681,313 $ (96,692)
Net income (loss) per share      
Basic ( in dollars per share) $ (2.52) $ 4.02 $ (0.62)
Diluted (in dollars per share) $ (2.52) $ 3.78 $ (0.62)
Weighted average shares outstanding used in computing net income (loss) per share      
Basic (in shares) 174,993 169,600 155,953
Diluted (in shares) 174,993 180,119 155,953
Product sales      
Revenue:      
Total revenue $ 20,117 $ 20,774 $ 32,688
Royalty revenue      
Revenue:      
Total revenue 41,222 41,976 33,527
Non-cash royalty revenue related to sale of future royalties      
Revenue:      
Total revenue 36,303 33,308 30,531
License, collaboration and other revenue      
Revenue:      
Total revenue $ 16,975 $ 1,097,265 $ 210,965